Facebook Linkedin RSS Twitter Youtube
Home 2023

Roche company

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise
Cancer

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise

Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody
Drug Discovery

Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody

StockWatch: Insilico CEO Breaks Down Exelixis Deal
Artificial Intelligence

StockWatch: Insilico CEO Breaks Down Exelixis Deal

Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer
Bioprocessing

Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer

StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy
Cancer

StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy

Making Medicines Based on Transplanting Differentiated Cells
Drug Discovery

Making Medicines Based on Transplanting Differentiated Cells

Lineage Cell Therapeutics Makes Medicines Based on Transplanting Differentiated Cells
GEN Edge

Lineage Cell Therapeutics Makes Medicines Based on Transplanting Differentiated Cells

Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment
Cancer

Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment

Rising Star: Vega Targets Rare Blood Disorders with Antibodies
GEN Edge

Rising Star: Vega Targets Rare Blood Disorders with Antibodies

Monoclonal Antibodies and Continuous Processing: A Case Study Examination
Bioprocessing

Monoclonal Antibodies and Continuous Processing: A Case Study Examination

1234...55Page 3 of 55
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.